Cargando…

Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali

BACKGROUND: Because of the emergence of chloroquine resistance in Mali, artemether-lumefantrine (AL) or artesunate-amodiaquine (AS+AQ) are recommended as first-line therapy for uncomplicated malaria, but have not been available in Mali until recently because of high costs. METHODS: From July 2005 to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kayentao, Kassoum, Maiga, Hamma, Newman, Robert D, McMorrow, Meredith L, Hoppe, Annett, Yattara, Oumar, Traore, Hamidou, Kone, Younoussou, Guirou, Etienne A, Saye, Renion, Traore, Boubacar, Djimde, Abdoulaye, Doumbo, Ogobara K
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631542/ https://www.ncbi.nlm.nih.gov/pubmed/19128455 http://dx.doi.org/10.1186/1475-2875-8-5

Ejemplares similares

Efficacy of sulphadoxine-pyrimethamine + artesunate, sulphadoxine-pyrimethamine + amodiaquine, and sulphadoxine-pyrimethamine alone in uncomplicated falciparum malaria in Mali
por: Maiga, Hamma, et al.
Publicado: (2015)

Effects of amodiaquine and artesunate on sulphadoxine-pyrimethamine pharmacokinetic parameters in children under five in Mali
por: Tekete, Mamadou M, et al.
Publicado: (2011)

Seasonal Malaria Chemoprevention with Sulphadoxine-Pyrimethamine and Amodiaquine Selects Pfdhfr-dhps Quintuple Mutant Genotype in Mali
por: Maiga, Hamma, et al.
Publicado: (2016)

Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali
por: Tekete, Mamadou, et al.
Publicado: (2009)

Parasite clearance following treatment with sulphadoxine-pyrimethamine for intermittent preventive treatment in Burkina-Faso and Mali: 42-day in vivo follow-up study
por: Coulibaly, Sheick O, et al.
Publicado: (2014)

Use of a pLDH-based dipstick in the diagnostic and therapeutic follow-up of malaria patients in Mali
por: Ouattara, Amed, et al.
Publicado: (2011)

Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali
por: Dicko, Alassane, et al.
Publicado: (2010)

Efficacy of Artesunate + Sulphadoxine-Pyrimethamine (AS + SP) and Amodiaquine + Sulphadoxine-Pyrimethamine (AQ + SP) for Uncomplicated falciparum Malaria in Equatorial Guinea (Central Africa)
por: Charle, Pilar, et al.
Publicado: (2009)

Efficacy and safety of a fixed dose artesunate-sulphamethoxypyrazine-pyrimethamine compared to artemether-lumefantrine for the treatment of uncomplicated falciparum malaria across Africa: a randomized multi-centre trial
por: Sagara, Issaka, et al.
Publicado: (2009)

Therapeutic efficacy of sulphadoxine-pyrimethamine and chloroquine for the treatment of uncomplicated malaria in pregnancy in Burkina Faso
por: Coulibaly, Sheick Oumar, et al.
Publicado: (2006)

The implementation of malaria intermittent preventive trialtreatment with sulphadoxine-pyrimethamine in infants reduced all-cause mortality in the district of Kolokani, Mali: results from a cluster randomized control
por: Dicko, Alassane, et al.
Publicado: (2012)

Efficacy of Artesunate + Sulfamethoxypyrazine/Pyrimethamine versus Praziquantel in the Treatment of Schistosoma haematobium in Children
por: Sissoko, Mahamadou S., et al.
Publicado: (2009)

Selection of pfcrt K76 and pfmdr1 N86 Coding Alleles after Uncomplicated Malaria Treatment by Artemether-Lumefantrine in Mali
por: Maiga, Hamma, et al.
Publicado: (2021)

Cost Effectiveness of Seasonal Intermittent Preventive Treatment Using Amodiaquine & Artesunate or Sulphadoxine-Pyrimethamine in Ghanaian Children
por: Conteh, Lesong, et al.
Publicado: (2010)

Efficacy and safety of artemether + lumefantrine, artesunate + sulphamethoxypyrazine-pyrimethamine and artesunate + amodiaquine and sulphadoxine-pyrimethamine + amodiaquine in the treatment of uncomplicated falciparum malaria in Bangui, Central African Republic: a randomized trial
por: Djallé, Djibrine, et al.
Publicado: (2014)

Effect of three years’ seasonal malaria chemoprevention on molecular markers of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine and amodiaquine in Ouelessebougou, Mali
por: Mahamar, Almahamoudou, et al.
Publicado: (2022)

Reduced ex vivo susceptibility of Plasmodium falciparum after oral artemether–lumefantrine treatment in Mali
por: Dama, Souleymane, et al.
Publicado: (2017)

Sulphadoxine/pyrimethamine versus amodiaquine for treating uncomplicated childhood malaria in Gabon: A randomized trial to guide national policy
por: Nsimba, Basile, et al.
Publicado: (2008)

Factors related to compliance to anti-malarial drug combination: example of amodiaquine/sulphadoxine-pyrimethamine among children in rural Senegal
por: Souares, Aurélia, et al.
Publicado: (2009)

128 A whole-blood transcriptional signature predicts parasite control and protection from malaria fever during natural Plasmodium falciparum infection
por: Tran, Tuan M., et al.
Publicado: (2014)

Co-infection of Long-Term Carriers of Plasmodium falciparum with Schistosoma haematobium Enhances Protection from Febrile Malaria: A Prospective Cohort Study in Mali
por: Doumbo, Safiatou, et al.
Publicado: (2014)

Impact of intermittent preventive treatment with sulphadoxine-pyrimethamine targeting the transmission season on the incidence of clinical malaria in children in Mali
por: Dicko, Alassane, et al.
Publicado: (2008)

A study of toxicity and differential gene expression in murine liver following exposure to anti-malarial drugs: amodiaquine and sulphadoxine-pyrimethamine
por: Mishra, Shrawan Kumar, et al.
Publicado: (2011)

Exposure-Dependent Control of Malaria-Induced Inflammation in Children
por: Portugal, Silvia, et al.
Publicado: (2014)

Impact of Three-Year Intermittent Preventive Treatment Using Artemisinin-Based Combination Therapies on Malaria Morbidity in Malian Schoolchildren
por: Maiga, Hamma, et al.
Publicado: (2020)

The Plasmodium falciparum-Specific Human Memory B Cell Compartment Expands Gradually with Repeated Malaria Infections
por: Weiss, Greta E., et al.
Publicado: (2010)

Delayed anemia assessment in patients treated with oral artemisinin derivatives for uncomplicated malaria: a pooled analysis of clinical trials data from Mali
por: Sagara, Issaka, et al.
Publicado: (2014)

Effects of Drug Policy Changes on Evolution of Molecular Markers of Plasmodium falciparum Resistance to Chloroquine, Amodiaquine, and Sulphadoxine-Pyrimethamine in the South West Region of Cameroon
por: Moyeh, Marcel N., et al.
Publicado: (2018)

Plasmodium falciparum Gametocyte-Specific Antibody Profiling Reveals Boosting through Natural Infection and Identifies Potential Markers of Gametocyte Exposure
por: Skinner, Jeff, et al.
Publicado: (2015)

Malaria-associated atypical memory B cells exhibit markedly reduced B cell receptor signaling and effector function
por: Portugal, Silvia, et al.
Publicado: (2015)

A nested real-time PCR assay for the quantification of Plasmodium falciparum DNA extracted from dried blood spots
por: Tran, Tuan M, et al.
Publicado: (2014)

Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapy
por: Mbacham, Wilfred F, et al.
Publicado: (2010)

Varying efficacy of artesunate+amodiaquine and artesunate+sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in the Democratic Republic of Congo: a report of two in-vivo studies
por: Bonnet, Maryline, et al.
Publicado: (2009)

Overall and Gender-Specific Effects of Intermittent Preventive Treatment of Malaria with Artemisinin-Based Combination Therapies among Schoolchildren in Mali: A Three-Group Open Label Randomized Controlled Trial
por: Maiga, Hamma, et al.
Publicado: (2022)

Two-Year Scale-Up of Seasonal Malaria Chemoprevention Reduced Malaria Morbidity among Children in the Health District of Koutiala, Mali
por: Maiga, Hamma, et al.
Publicado: (2020)

Antibodies to malaria vaccine candidates are associated with chloroquine or sulphadoxine/pyrimethamine treatment efficacy in children in an endemic area of Burkina Faso
por: Diarra, Amidou, et al.
Publicado: (2012)

The usefulness of twenty-four molecular markers in predicting treatment outcome with combination therapy of amodiaquine plus sulphadoxine-pyrimethamine against falciparum malaria in Papua New Guinea
por: Marfurt, Jutta, et al.
Publicado: (2008)

Combination of probenecid-sulphadoxine-pyrimethamine for intermittent preventive treatment in pregnancy
por: Gutman, Julie, et al.
Publicado: (2012)

Declining efficacy of artesunate plus sulphadoxine-pyrimethamine in northeastern India
por: Mishra, Neelima, et al.
Publicado: (2014)

Efficacy of artesunate–amodiaquine, dihydroartemisinin–piperaquine and artemether–lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Maradi, Niger
por: Grandesso, Francesco, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hjq18mv4vrh76v9pen3ad4sto4